⌘K

NeuroBo Pharmaceuticals, Inc. (NRBO)

$3.40 0.10% $0.00 Healthcare

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene, an acute indication for COVID-19. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.

Market cap

$28.88M

CEO

Mr. Joseph Hooker

Full time employees

5.00

Headquarters

Boston, MA

IPO Date

Aug 05, 2016

Price-to-earnings (PE) Ratio

-0.68

Earnings-per-share (EPS)

$-4.99

Cash ratio (TTM)

2.88

Current ratio (TTM)

2.94

Net profit margin (TTM)

-647,475.00%

PE ratio (TTM)

-0.72

PEG ratio (TTM)

-0.00

Price-to-book ratio (TTM)

0.98

Price-to-sales ratio (TTM)

7,277.43

Quick ratio (TTM)

2.94

Return on assets (TTM)

-90.08%

Return on equity (TTM)

-154.04%

Similar stocks (10)

Kiora Pharmaceuticals, Inc.

KPRX

$3.67 1.38% $0.05

Downtrend

Cardio Diagnostics Holdings, Inc.

CDIO

$0.29 5.45% $0.02

Downtrend

Sonnet BioTherapeutics Holdings, Inc.

SONN

$1.05 4.91% $0.05

Downtrend

Revelation Biosciences, Inc.

REVB

$0.87 0.46% $0.00

Downtrend

Phio Pharmaceuticals Corp.

PHIO

$3.64 -0.41% $-0.02

Downtrend

Allarity Therapeutics, Inc.

ALLR

$2.20 -4.35% $-0.10

Downtrend

Kiromic BioPharma, Inc.

KRBP

$1.60 -5.33% $-0.09

Downtrend

Quoin Pharmaceuticals, Ltd.

QNRX

$0.56 -2.91% $-0.02

Downtrend

180 Life Sciences Corp.

ATNF

$2.00 -1.48% $-0.03

Downtrend

PaxMedica, Inc.

PXMD

$0.09 0.00% $0.00

Downtrend

ETF Exposure (7)

Dimensional U.S. Small Cap ETF

DFAS

3.9e-6%

$64.76 1.58% $1.01

Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

1.06e-6%

$55.73 1.69% $0.92

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$281.91 1.65% $4.56

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.71 1.88% $3.37

Uptrend

Downtrend

Similar stocks (10)

Kiora Pharmaceuticals, Inc.

KPRX

$3.67 1.38% $0.05

Downtrend

Cardio Diagnostics Holdings, Inc.

CDIO

$0.29 5.45% $0.02

Downtrend

Sonnet BioTherapeutics Holdings, Inc.

SONN

$1.05 4.91% $0.05

Downtrend

Revelation Biosciences, Inc.

REVB

$0.87 0.46% $0.00

Downtrend

Phio Pharmaceuticals Corp.

PHIO

$3.64 -0.41% $-0.02

Downtrend

Allarity Therapeutics, Inc.

ALLR

$2.20 -4.35% $-0.10

Downtrend

Kiromic BioPharma, Inc.

KRBP

$1.60 -5.33% $-0.09

Downtrend

Quoin Pharmaceuticals, Ltd.

QNRX

$0.56 -2.91% $-0.02

Downtrend

180 Life Sciences Corp.

ATNF

$2.00 -1.48% $-0.03

Downtrend

PaxMedica, Inc.

PXMD

$0.09 0.00% $0.00

Downtrend

ETF Exposure (7)

Dimensional U.S. Small Cap ETF

DFAS

3.9e-6%

$64.76 1.58% $1.01

Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

1.06e-6%

$55.73 1.69% $0.92

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$281.91 1.65% $4.56

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.71 1.88% $3.37

Uptrend